---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-042017"
form_type: "8-K/A"
ticker: "APUS"
cik: "0001894525"
company_name: "Apimeds Pharmaceuticals US, Inc."
filed_at: "2026-04-09T23:59:59+00:00"
generated_at: "2026-05-15T06:49:38.356106+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Apimeds: Majority stockholder consent to remove directors/officers is null and void

## Summary
- Inscobee Inc. and Apimeds, Inc. attempted written consent to remove directors Kogan, Koo, O’Donnell, Weintraub and officers Menon (CEO) and Frim (CFO).
- Company determined consent invalid due to violations of irrevocable proxy, consent waiver, and anti-frustration covenant in Support Agreement.
- Support Agreement expressly states any action taken in violation is null and void; consent void ab initio.
- Company will proceed with actions described in Schedule 14C Information Statement filed Feb 27, 2026, mailed March 5, 2026.
- This Amendment No. 1 clarifies the previously reported actions are of no force or effect.

## SEC filing metadata
- accession: 0001213900-26-042017
- form_type: 8-K/A
- ticker: APUS
- cik: 0001894525
- company_name: Apimeds Pharmaceuticals US, Inc.
- filed_at: 2026-04-09T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894525/000121390026042017/0001213900-26-042017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894525/000121390026042017/ea0285032-8ka425_apimeds.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-042017
- JSON: https://secwatch.observer/filing/0001213900-26-042017.json
- Plain text: https://secwatch.observer/filing/0001213900-26-042017.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.